These included, but were not limited to the finding that CB1, CB2 and GPR18 were down-regulated, whereas TRPV1 and TRPV2 were up-regulated at the mRNA level in itchy lesional skin of AD patients [276]. This evidence concerns the gene CNR1 and Alzheimer disease.